Purpureocillium lilacinum as a cause of cavitary pulmonary disease: A new clinical presentation and observations on atypical morphologic characteristics of the isolate

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1800-1804

  Khan, Ziauddin ^a   Ahmad, Suhail ^a   Al Ghimlas, Fahad ^b   Al Mutairi, Sana ^a,b   Joseph, Leena ^a   Chandy, Rachel ^a   Sutton, Deanna A ^c   Guarro, Josep ^d  

^a KUWAIT UNIVERSITY   (Kuwait)

^b AL AMIRI HOSPITAL   (Kuwait)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; ITRACONAZOLE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; VORICONAZOLE;

ACREMONIUM; AGED; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CAVITARY PULMONARY DISEASE; COUGHING; DEATH; DRUG EFFICACY; FEMALE; FEVER; FUNGUS ISOLATION; FUSARIUM; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; LUNG DISEASE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAECILOMYCES; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PURPUREOCILLIUM LILACINUM; REMISSION; TACHYCARDIA; TACHYPNEA; THORAX PAIN; WHEEZING;

AGED, 80 AND OVER; ANTIFUNGAL AGENTS; DNA, FUNGAL; FEMALE; HUMANS; HYPOCREALES; LUNG DISEASES, FUNGAL; MICROSCOPY; MOLECULAR SEQUENCE DATA; MYCOSES; PYRIMIDINES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; TRIAZOLES;

EID: 84859980372     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00150-12     Document Type: Article

References (39)

1. Aguilar C, Pujol I, Sala J, Guarro J. 1998. Antifungal susceptibilities of Paecilomyces species. Antimicrob. Agents Chemother. 42:1601-1604. (Pubitemid 28311549)
2. Ahmad S, Khan ZU, Theyyathel AM. 2007. Diagnostic value of DNA, (1-3)-beta-D-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus. Diagn. Microbiol. Infect. Dis. 59:165-171. (Pubitemid 47496092)
3. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. 2005. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 48:347-351. (Pubitemid 41656983)
4. Antas PR, Brito MM, Peixoto E, Ponte CG, Borba CM. 2012. Neglected and emerging fungal infections: review of hyalohyphomycosis by Paecilo-myces lilacinus focusing in disease burden, in vitro antifungal susceptibility and management. Microbes Infect. 14:1-8.
5. Castelli MV, et al. 2008. Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrob. Agents Chemother. 52:2926-2928.
6. Ciecko SC, Scher R. 2010. Invasive fungal rhinitis caused by Paecilomyces lilacinus infection: report of a case and a novel treatment. Ear Nose Throat J. 89:594-595.
7. de Hoog G, Guarro J, Gené J, Figueras MJ. 2000. Atlas of clinical fungi, 2nd ed, p 794-809. Reus, Utrecht, The Netherlands.
8. Del Poeta M, Schell WA, Perfect JR. 1997. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob. Agents Chemother. 41:1835-1836. (Pubitemid 27339900)
9. Fenech FF, Mallia CP. 1972. Pleural effusion caused by Penicillium lilacinum. Br. J. Dis. Chest 66:284-290.
10. Garzoni C, Garbino J. 2008. New azoles as first line therapy for Paecilomyces lilacinus in transplant patients. Transpl. Infect. Dis. 10:149-150. (Pubitemid 351393088)
11. González GM, Fothergill AW, Sutton DA, Rinaldi MG, Loebenberg D. 2005. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi. Med. Mycol. 43:281-284. (Pubitemid 40867502)
12. Gucalp R, et al. 1996. Paecilomyces sinusitis in an immunocompromised adult patient: case report and review. Clin. Infect. Dis. 23:391-393. (Pubitemid 26264925)
13. Gutiérrez F, et al. 2005. Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections. Eur. J. Clin. Microbiol. Infect. Dis. 24:607-611. (Pubitemid 41456141)
14. Houbraken J, Verweij PE, Rijs AJ, Borman AM, Samson RA. 2010. Identification of Paecilomyces variotii in clinical samples and settings. J. Clin. Microbiol. 48:2754-2761.
15. Itin PH, et al. 1998. Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J. Am. Acad. Dermatol. 39:401-409. (Pubitemid 28417374)
16. Khan Z, et al. 2010. Cryptococcus randhawai sp. nov., a novel anamorphic basidiomycetous yeast isolated from tree trunk hollow of Ficus religiosa (peepal tree) from New Delhi, India. Antonie Van Leeuwenhoek 97:253-259.
17. Khan Z, et al. 2011. Acremonium kiliense: reappraisal of its clinical significance. J. Clin. Microbiol. 49:2342-2347.
18. Labriola L, Ercam VB, Swinne D, Jadoul M. 2009. Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient. Clin. Nephrol. 71:355-358.
19. Liu K, Howell DN, Perfect JR, Schell WA. 1998. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am. J. Clin. Pathol. 109:45-54. (Pubitemid 28023810)
20. Luangsa-Ard, J, et al. 2011. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol. Lett. 321:141-149.
21. Martin CA, Roberts S, Greenberg RN. 2002. Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome. Clin. Infect. Dis. 35:e78-e81.
22. Mormede M, et al. 1984. Isolement d'un Paecilomyces (P. lilacinus) à partir d'un épanchement pleural. Méd. Malad. Infect. 14:76-78. (Pubitemid 14131746)
23. Nayak DR, Balakrishnan R, Nainani S, Siddique S. 2000. Paecilomyces fungus infection of the paranasal sinuses. Int. J. Pediatr. Otorhinolaryngol. 52:183-187. (Pubitemid 30190109)
24. Nucci M, Anaissie E. 2007. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev. 20:695-704. (Pubitemid 47623773)
25. Okada G, Sakai N, Yamagishi M. 1995. Acremonium-like submerged conidiation in Paecilomyces nostocoides and P. lilacinus. Mycoscience 36: 345-351.
26. Ono N, Sato K, Yokomise H, Tamura K. 1999. Lung abscess caused by Paecilomyces lilacinus. Respiration 66:85-87. (Pubitemid 29090001)
27. Orth B, et al. 1996. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann. Intern. Med. 125:799-806. (Pubitemid 126449717)
28. Ounissi M, et al. 2009. Hyalohyphomycosis caused by Paecilomyces lilacinus after kidney transplantation. Transplant. Proc. 41:2917-2919.
29. Pastor FJ, Guarro J. 2006. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin. Microbiol. Infect. 12:948-960. (Pubitemid 44322566)
30. Pawloski DR, Brunker JD, Singh K, Sutton DA. 2010. Pulmonary Paecilomyces lilacinus infection in a cat. J. Am. Anim. Hosp. Assoc. 46:197-202.
31. Permi HS, et al. 2011. A rare case of fungal maxillary sinusitis due to Paecilomyces lilacinus in an immunocompetent host presenting as a sub-cutaneous swelling. J. Lab. Physicians 3:46-48.
32. Rockhill RC, Klein MD. 1980. Paecilomyces lilacinus as the cause of chronic maxillary sinusitis. J. Clin. Microbiol. 11:737-739. (Pubitemid 10119987)
33. Rodríguez MM, Pastor FJ, Serena C, Guarro J. 2010. Efficacy of voriconazole in a murine model of invasive paecilomycosis. Int. J. Antimicrob. Agents 35:362-365.
34. Rosmaninho A, et al. 2010. Paecilomyces lilacinus in transplant patients: an emerging infection. Eur. J. Dermatol. 20:643-644.
35. Rowley SD, Strom CG. 1982. Paecilomyces fungus infection of the maxillary sinus. Laryngoscope 92:332-334. (Pubitemid 12187108)
36. Saberhagen C, Klotz SA, Bartholomew W, Drews D, Dixon A. 1997. Infection due to Paecilomyces lilacinus: a challenging clinical identification. Clin. Infect. Dis. 25:1411-1413. (Pubitemid 28022681)
37. Sillevis Smitt JH, Leusen JH, Stas HG, Teeuw AH, Weening RS. 1997. Chronic bullous disease of childhood and a Paecilomyces lung infection in chronic granulomatous disease. Arch. Dis. Child. 77:150-152. (Pubitemid 27398220)
38. Uchida K, Nishiyama Y, Yokota N, Yamaguchi H. 2000. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. J. Antibiot. (Tokyo) 53:1175-1181.
39. Van Schooneveld T, et al. 2008. Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature. Transpl. Infect. Dis. 10:117-122. (Pubitemid 351393080)